Unleashing potent antimicrobial synergy: Carnosic acid and caffeic acid tackle multidrug-resistant MRSA
Rulin Jin,
No information about this author
Yating Wang,
No information about this author
Weiqing Lan
No information about this author
et al.
Food Bioscience,
Journal Year:
2025,
Volume and Issue:
unknown, P. 106650 - 106650
Published: April 1, 2025
Language: Английский
Phytochemical Composition and Bioactivities of Some Hydrophytes: Antioxidant, Antiparasitic, Antibacterial, and Anticancer Properties and Mechanisms
Plants,
Journal Year:
2024,
Volume and Issue:
13(15), P. 2148 - 2148
Published: Aug. 2, 2024
Few
researches
have
explored
the
production
of
pharmaceuticals
from
aquatic
plants.
Therefore,
this
study
explored,
for
first
time,
phytochemical
composition
and
bioactivities
ten
Aquatic
plant
shoots
various
Nile
River
canals
were
collected,
dried,
ground
aqueous
extract
preparation.
Phytochemical
antioxidant
capacity
assessed
using
DPPH
assays.
Extracts
tested
antiparasitic,
antibacterial,
anti-biofilm,
anticancer
activities
through
standard
in
vitro
assays,
measuring
IC50
values,
evaluating
mechanisms
action,
including
cell
viability
high-content
screening
The
results
showed
that
plants
rich
pharmaceutical
compounds.
these
extracts
exceeded
vitamin
C.
promising
antiparasitic
activity
against
pathogens
like
Opisthorchis
viverrini
Plasmodium
falciparum,
with
values
between
0.7
2.5
µg/mL.
They
also
demonstrated
low
MICs
pathogenic
bacteria,
causing
DNA
damage,
increased
plasma
membrane
permeability,
90%
biofilm
inhibition.
In
terms
activity,
effective
a
panel
cancer
lines,
Ludwigia
stolonifera
exhibiting
highest
efficacy.
Its
ranged
0.5
µg/mL
pancreatic,
esophageal,
colon
cells
to
1.5
gastric
cells.
Overall,
all
below
6
µg/mL,
showing
significant
apoptotic
nuclear
intensity,
mitochondrial
cytochrome
c
release,
outperforming
doxorubicin.
This
highlights
potential
as
sources
new,
safe,
drugs
strong
properties.
Language: Английский
Synthesis, kinetics, mechanisms, and bioactivity evaluations of a novel Zn(ii) complex
Anwesha Dey,
No information about this author
Ramesh Kumar,
No information about this author
Bhramar Dutta
No information about this author
et al.
RSC Advances,
Journal Year:
2024,
Volume and Issue:
14(39), P. 28693 - 28702
Published: Jan. 1, 2024
Zn(
ii
)-based
anticancer
drugs
can
be
suitable
alternatives
to
conventional
Pt(
because
of
the
unique
chemical
properties
)
and
low
toxicity.
Language: Английский